StylAge M (2x1ml) | Vivacy | Wholesale Aesthetic Pharma
This shop uses cookies and other technologies so that we can improve your experience on our sites. close
Reduced price!

StylAge M (2x1ml)

New product

497,22 zł tax excl.

828,70 zł tax excl.




Introduced to the UK in approximately 2011 and manufactured by the French company Vivacy Laboratories, Stylage® is the first hyaluronic acid dermal filler with local anaesthetic lidocaine (lignocaine) and an antioxidant, in the form of mannitol, all within one product. The presence of mannitol, the "free radical scavenger", limits the devastating effects of free radicals on the dermis and product injected, thus reducing the risk of post-injection inflammation and preventing the gel's structure degradation.

With their patented IPN-like® Technology (Interpenetrated Network), Vivacy has created something which has two structures—the monophasic A and B structure, and the IPN-like structure. The two are mechanically independent, so Stylage is easy to inject and the increased density of its cross-linking nodes make it long-lasting. This methods requires less BDDE (a common compound used in cross linking hyauronic acids) which the company claims is more effective and results in a safer, longer lasting product. 

Stylage® M is specifically designed for medium to deep wrinkles. 

The duration of the effect of a Stylage® M treatment is up to 12 months. It's very individual and depends on many factors, such as the patient's skin type and structure, age, lifestyle, the area treated and the injection technique used by the practitioner..


Stylage® M is an injectable implant indicated for filling medium to deep wrinkles, by injection into the middle dermis  

  • moderate to severe naso-labial folds,
  • smoothing of wrinkled areas and sagging folds (cheeks, facial oval, chin),
  • oral commissures (marionette lines),
  • cheek wrinkles,
  • hollow temple area,
  • the nose for nasal hump reduction,
  • nasal tip lift,
  • earlobe reshaping,
  • rejuvenating the hands by sub-cutaneous injection in the back of the hand,
  • enhancing the lip outline and lip augmentation.


Cross-linked hyaluronic acid IPN-Like: 20 mg/g

Lidocaine: -

Mannitol q.s. 1g

Phosphate buffer pH: 7,2


2 x 1 ml prefilled syringe

needles: 4 x 30G 1/2

  • hypersensitivity to one of the components,
  • skin infection near the site of injection,
  • patients susceptible to keloid formation,
  • pregnant or lactating women,
  • allergy or anaphylaxis,
  • bleeding disorders,
  • autoimmune disorders,
  • antibiotic therapy.

Read the package leaflet before use.


SAFETY only original products
CALENDAR terms congresses
NEWS in aesthetic medicine